1 Mertens A C, Yasui Y, Neglia J P, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the childhoodcancer survivor study. J Clin Oncol, 2001, 19: 3163-3172
[2]
2 Mainio A, Hakko H, Timonen M, et al. Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-yearfollow-up study. Neurosurgery, 2005, 56: 1234-1241？？
[3]
3 Sant M, Van der Sanden G, Capocaccia R. Survival rates for primary malignant brain tumours in Europe. EUROCARE working group. EurJ Cancer, 1998, 34: 2241-2247？？
[4]
4 Barnholtz-Sloan J S, Sloan A E, Schwartz A G. Relative survival rates and patterns of diagnosis analyzed by time period for individuals with primary malignant brain tumor, 1973-1997. J Neurosurg, 2003, 99: 458-466
[5]
5 Iwadate Y, Sakaida T, Hiwasa T, et al. Molecular classification and survival prediction in human gliomas based on proteome analysis.Cancer Res, 2004, 64: 2496-2501？？
[6]
6 Engelhard H H, Stelea A, Cochran E J. Oligodendroglioma: pathology and molecular biology. Surg Neurol, 2002, 58: 111-117？？
[7]
7 Rickert C H, Paulus W. Prognosis-related histomorphological and immunohistochemical markers in central nervous system tumors ofchildhood and adolescence. Acta Neuropathol, 2005, 109: 69-92？？
[8]
8 Zarbo R J, Meier F A, Raab S S. Error detection in anatomic pathology. Arch Pathol Lab Med, 2005, 129: 1237-1245
[9]
9 Salpietro F M, Alafaci C, Lucerna S, et al. Peritumoral edema in meningiomas microsurgical observations of different brain tumor interfacesrelated to computed tomography. Neurosurgery, 1994, 35: 638-641？？
[10]
10 Simonetti A W, Melssen W J, Szabo de Edelenyi F, et al. Combination of feature-reduced MR spectroscopic and MR imaging data forimproved brain tumor classification. NMR Biomed, 2005, 18: 34-43？？
[11]
11 Devos A, Simonetti A W, Van der Graaf M, et al. The use of multivariate MR imaging intensities versus metabolic data from MRspectroscopic imaging for brain tumour classification. J Magn Reson, 2005, 173: 218-228？？
[12]
12 Henze M, Mohammed A, Schlemmer H P, et al. PET and SPECT for detection of tumor progression in irradiated low-grade astrocytoma: areceiver-operating-characteristic analysis. J Nucl Med, 2004, 45: 579-586
[13]
13 Roelcke U, Leenders K L. PET in neuro-oncology. J Cancer Res Clin Oncol, 2001, 127: 2-8？？
[14]
14 Tong Z, Yamaki T, Harada K, et al. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopyusing water as an internal standard. Magn Reson Imaging, 2004, 22: 1017-1024？？
[15]
15 Fayed N, Morales H, Modrego P J, et al. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopyaccurately discriminate low-grade from high-grade cerebral gliomas. Acad Radiol, 2006, 13: 728-737？？
[16]
16 Majos C, Alonso J, Aguilera C, et al. Proton magnetic resonance spectroscopy (1H MRS) of human brain tumours: assessment of differencesbetween tumour types and its applicability in brain tumour categorization. Eur Radiol, 2003, 13: 582-591
[17]
17 Majos C, Julia-Sape M, Alonso J, et al. Brain tumor classification by proton MR spectroscopy: comparison of diagnostic accuracy at shortand long TE. AJNR Am J Neuroradiol, 2004, 25: 1696-1704
[18]
18 Maxwell R J, Martinez-Perez I, Cerdan S, et al. Pattern recognition analysis of 1H NMR spectra from perchloric acid extracts of humanbrain tumor biopsies. Magn Reson Med, 1998, 39: 869-877？？
[19]
19 Lehnhardt F G, Bock C, Rohn G, et al. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopicinvestigation. NMR Biomed, 2005, 18: 371-382？？
[20]
20 Tugnoli V T M, Bertoluzza A, Barbarella G, et al. In vitro magnetic resonance spectroscopy of health and neoplastic brain tissues. J MolStruct, 1999, 482: 365-369
[21]
21 Peeling J, Sutherland G. High-resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn Reson Med, 1992,24: 123-136？？
[22]
22 Wilson M, Davies N P, Grundy R G, et al. A quantitative comparison of metabolite signals as detected by in vivo MRS with ex vivo 1HHR-MAS for childhood brain tumours. NMR Biomed, 2009, 22: 213-219？？
[23]
23 Yang Y, Li C, Nie X, et al. Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMRspectroscopy in conjunction with multivariate data analysis. J Proteome Res, 2007, 6: 2605-2614？？
[24]
24 RighiV, Roda J M, Paz J, et al. 1H HR-MAS and genomic analysis of human tumor biopsies discriminate between high and low gradeastrocytomas. NMR Biomed, 2009, 22: 629-637？？
[25]
25 Chen W X, Lou H Y, Zhang H P, et al. Metabonomic characterization of the low-grade human astrocytomas and meningiomas usingmagic-angle spinning 1H nuclear magnetic resonance spectroscopy and principal component analysis. Prog Biochem Biophys, 2008, 35:1142-1153
[26]
26 Waters N J, Garrod S, Farrant R D, et al. High-resolution magic angle spinning 1H NMR spectroscopy of intact liver and kidney: optimization ofsample preparation procedures and biochemical stability of tissue during spectral acquisition. Anal Biochem, 2000, 282: 16-23？？
[27]
27 Wang Y, Holmes E, Nicholson J K, et al. Metabonomic investigations in mice infected with Schistosoma mansoni: an approach forbiomarker identification. Proc Natl Acad Sci USA, 2004, 101: 12676-12681？？
[28]
28 Cheng L L, Burns M A, Taylor J L, et al. Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy.Cancer Res, 2005, 65: 3030-3034
[29]
29 Nicholls A W, Mortishire-Smith R J. Temperature calibration of a high-resolution magic-angle spinning NMR probe for analysis of tissuesamples. Magn Reson Chem, 2001, 39: 773-776？？
[30]
30 Wang Y, Bollard M E, Keun H, et al. Spectral editing and pattern recognition methods applied to high-resolution magic-angle spinning 1Hnuclear magnetic resonance spectroscopy of liver tissues. Anal Biochem, 2003, 323: 26-32？？
[31]
31 Eriksson L J E, Kettanah-Wold N. Introduction to multi and megavariate data analysis using projection methods (PCA and PLS-DA)1992-2002. Sweden: Umetrics AB, 2002
[32]
32 Brindle J T, Antti H, Holmes E, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using1H-NMR-based metabonomics. Nat Med, 2002, 8: 1439-1444？？
[33]
33 Wold S, Antti H, Lindgren F, et al. Orthogonal signal correction of near-infrared spectra. Chemometr Intell Lab, 1998, 44: 175-185？？
[34]
34 Howe F A, Barton S J, Cudlip S A, et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonancespectroscopy. Magn Reson Med, 2003, 49: 223-232？？
[35]
35 Govindaraju V, Young K, Maudsley A A. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed, 2000,13: 129-153？？
[36]
36 Kinoshita Y, Yokota A. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonancespectroscopy. NMR Biomed, 1997, 10: 2-12？？
[37]
37 Cheng L L, Anthony D C, Comite A R, et al. Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolutionmagic-angle spinning (HRMAS) proton magnetic resonance spectroscopy. Neuro Oncology, 2000, 2: 87-95
[38]
38 Meyerand M E, Pipas J M, Mamourian A, et al. Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy.AJNR Am J Neuroradiol, 1999, 20: 117-123
[39]
39 Koljenovic S, Choo-Smith L P, Bakker Schut T C, et al. Discriminating vital tumor from necrotic tissue in human glioblastoma tissuesamples by Raman spectroscopy. Lab Invest, 2002, 82: 1265-1277
[40]
40 Fayed N, Davila J, Medrano J, et al. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamicsusceptibility contrast MRI. Eur J Radiol, 2008, 67: 427-433？？
[41]
41 Roda J M, Pascual J M, Carceller F, et al. Nonhistological diagnosis of human cerebral tumors by 1H magnetic resonance spectroscopy andamino acid analysis. Clin Cancer Res, 2000, 6: 3983-3993
[42]
42 Lehnhardt F G, Rohn G, Ernestus R I, et al. 1H- and 31P-MR spectroscopy of primary and recurrent human brain tumors in vitro:malignancy-characteristic profiles of water soluble and lipophilic spectral components. NMR Biomed, 2001, 14: 307-317？？
[43]
43 Cheng L L, Chang I W, Louis D N, et al. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy withhistopathology of intact human brain tumor specimens. Cancer Res, 1998, 58: 1825-1832
[44]
44 Wilson M, Davies N P, Brundler M A, et al. High resolution magic angle spinning 1H NMR of childhood brain and nervous system tumours.Mol Cancer, 2009, 8: 6-16？？
[45]
45 Lukas L, Devos A, Suykens J A, et al. Brain tumor classification based on long echo proton MRS signals. Artif Intell Med, 2004, 31: 73-89？？
